CA966778A - Antigens and antibodies - Google Patents
Antigens and antibodiesInfo
- Publication number
- CA966778A CA966778A CA112,764A CA112764A CA966778A CA 966778 A CA966778 A CA 966778A CA 112764 A CA112764 A CA 112764A CA 966778 A CA966778 A CA 966778A
- Authority
- CA
- Canada
- Prior art keywords
- antigens
- antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA219,741A CA985169A (en) | 1970-05-13 | 1975-02-10 | Method for the determination of an opium alkaloid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3699970A | 1970-05-13 | 1970-05-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA966778A true CA966778A (en) | 1975-04-29 |
Family
ID=21891894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA112,764A Expired CA966778A (en) | 1970-05-13 | 1971-05-12 | Antigens and antibodies |
Country Status (5)
Country | Link |
---|---|
CA (1) | CA966778A (en) |
DE (1) | DE2166716C3 (en) |
DK (1) | DK142145B (en) |
GB (1) | GB1320056A (en) |
SE (4) | SE389739B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4104367A (en) * | 1976-10-13 | 1978-08-01 | Hoffmann-La Roche Inc. | Radioimmunoassay for methadone |
CN113968853B (en) * | 2020-07-22 | 2022-09-16 | 中国农业大学 | Hapten and artificial antigen of atropine alkaloid, and preparation method and application thereof |
-
1971
- 1971-05-11 DE DE2166716A patent/DE2166716C3/en not_active Expired
- 1971-05-12 CA CA112,764A patent/CA966778A/en not_active Expired
- 1971-05-12 DK DK228271AA patent/DK142145B/en unknown
- 1971-05-13 GB GB1462971*[A patent/GB1320056A/en not_active Expired
- 1971-05-13 SE SE7408141A patent/SE389739B/en not_active IP Right Cessation
- 1971-05-13 SE SE7106271A patent/SE389737B/en unknown
-
1974
- 1974-06-19 SE SE7408141A patent/SE7408141L/xx unknown
- 1974-06-19 SE SE7408140A patent/SE417970B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE2166716A1 (en) | 1975-04-24 |
SE417970B (en) | 1981-04-27 |
DK142145B (en) | 1980-09-08 |
SE7408140L (en) | 1974-06-19 |
SE389739B (en) | 1976-11-15 |
SE389737B (en) | 1976-11-15 |
GB1320056A (en) | 1973-06-13 |
DE2166716B2 (en) | 1979-09-27 |
DE2123300A1 (en) | 1971-11-25 |
DK142145C (en) | 1981-02-02 |
SE7408141L (en) | 1974-06-19 |
DE2166716C3 (en) | 1980-06-12 |
DE2123300B2 (en) | 1976-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA988420A (en) | Direct radioimmunoassay for antigens and their antibodies | |
CA982140A (en) | Phenoxy-hydroxypropylamines and their preparation | |
AU462240B2 (en) | Fusing process and device | |
CA962594A (en) | Labeled antibody reagent | |
CA965351A (en) | Carcinoembryonic antigen | |
CA936408A (en) | Non-isoelectric protein and method | |
CA939180A (en) | Toner materials and method | |
CA966778A (en) | Antigens and antibodies | |
CA942555A (en) | Development method and materials | |
CA1022923A (en) | Antigens | |
CA955247A (en) | Cephalosporins and preparation thereof | |
CA980337A (en) | Hapten and antigen derivatives | |
AU459764B2 (en) | Carcinoembryonic antigen | |
AU460071B2 (en) | Carcinoembryonic antigen | |
CA842760A (en) | Stabilized antigens and means for the production thereof | |
CA846123A (en) | Photosensitive methods and materials | |
CA853628A (en) | Photographic methods and materials | |
CA839754A (en) | O-acylbenzohydroxamate and preparation thereof | |
CA1016183A (en) | Thioxanthen-9-ones and preparation thereof | |
CA838091A (en) | 1-substituted-3-cyclohexenes and preparation thereof | |
CA965797A (en) | Bisphosphorylated imidodithiocarbonates and methods for their preparation | |
AU1646270A (en) | Carcinoembryonic antigen | |
AU441197B2 (en) | Novel thienodiazepines and preparations thereof | |
CA845173A (en) | Heterolinear tetraphenylbutadienes and preparation | |
CA846850A (en) | N-hexahydromethanoindanyl-dimethylthioureas and preparation |